Neuroprotective effects of glucose-dependent insulinotropic polypeptide in Alzheimer's disease (Q38583347)

4 September 2017

Neuroprotective effects of glucose-dependent insulinotropic polypeptide in Alzheimer's disease (English)

1 reference

4 September 2017

0 references

5

1 reference

4 September 2017

Chenhui Ji

1

1 reference

4 September 2017

Guo-Fang Xue

series ordinal

2

1 reference

4 September 2017

Guanglai Li

series ordinal

3

1 reference

4 September 2017

Dongfang Li

series ordinal

4

1 reference

4 September 2017

5 September 2015

1 reference

Reviews in the Neurosciences

4 September 2017

1 reference

4 September 2017

27

1 reference

4 September 2017

61-70

1 reference

4 September 2017

1

1 reference

Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention

4 September 2017

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO-2015-0021

Gut hormones as therapeutic agents in treatment of diabetes and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO-2015-0021

Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in Type 2 diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO-2015-0021

Nitric oxide, the enigmatic neuronal messenger: its role in synaptic plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO-2015-0021

Glucose-dependent insulinotropic polypeptide is expressed in adult hippocampus and induces progenitor cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO-2015-0021

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO-2015-0021

Administration of an acylated GLP-1 and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with Type 2 diabetes and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO-2015-0021

Systemic infections and inflammation affect chronic neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO-2015-0021

Insulin-like growth factor I and Alzheimer's disease: therapeutic prospects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO-2015-0021

Transcriptional analysis of apoptotic cerebellar granule neurons following rescue by gastric inhibitory polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO-2015-0021

Stress primes microglia to the presence of systemic inflammation: implications for environmental influences on the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO-2015-0021

The incretin hormones glucagonlike peptide 1 and glucose-dependent insulinotropic polypeptide are neuroprotective in mouse models of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO-2015-0021

First clinical data of the neuroprotective effects of nasal insulin application in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO-2015-0021

The contribution of activated astrocytes to Aβ production: implications for Alzheimer's disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO-2015-0021

Cognition and synaptic plasticity in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO-2015-0021

Glucagon‐like peptide 1 modulates calcium responses to glutamate and membrane depolarization in hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO-2015-0021

Pharmacology, physiology, and mechanisms of incretin hormone action

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO-2015-0021

Role of the glucose-dependent insulinotropic polypeptide and its receptor in the central nervous system: therapeutic potential in neurological diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO-2015-0021

Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO-2015-0021

Glucose-dependent insulinotropic polypeptide-mediated up-regulation of beta-cell antiapoptotic Bcl-2 gene expression is coordinated by cyclic AMP (cAMP) response element binding protein (CREB) and cAMP-responsive CREB coactivator 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO-2015-0021

Association of diabetes with amnestic and nonamnestic mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO-2015-0021

Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO-2015-0021

Brain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO-2015-0021

Insulin and the CNS: effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO-2015-0021

Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO-2015-0021

Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO-2015-0021

10.1515/REVNEURO-2015-0021

21 January 2018

Identifiers

DOI

1 reference

4 September 2017

1 reference